BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,991,200 | +101.7% | 655,000 | +118.3% | 0.01% | +14.3% |
| Q2 2023 | $987,000 | -48.3% | 300,000 | -50.0% | 0.01% | -12.5% |
| Q1 2023 | $1,908,000 | +512.7% | 600,000 | +1233.3% | 0.01% | +166.7% |
| Q4 2022 | $311,400 | -64.9% | 45,000 | -67.9% | 0.00% | -62.5% |
| Q3 2022 | $886,000 | -40.3% | 140,000 | +409.1% | 0.01% | -63.6% |
| Q3 2020 | $1,484,000 | -30.5% | 27,500 | -21.4% | 0.02% | -40.5% |
| Q2 2020 | $2,136,000 | +16.2% | 35,000 | -12.5% | 0.04% | -19.6% |
| Q1 2020 | $1,838,000 | -67.9% | 40,000 | -11.1% | 0.05% | -64.9% |
| Q2 2019 | $5,724,000 | +142.5% | 45,000 | +200.0% | 0.13% | +336.7% |
| Q1 2019 | $2,360,000 | +5.0% | 15,000 | -2.6% | 0.03% | +7.1% |
| Q3 2018 | $2,248,000 | – | 15,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |